NORDEA INVESTMENT MANAGEMENT AB

Position in NBIX — Neurocrine Biosciences Inc

CIK 1218210 STOCKHOLM, V7

Back to NBIX Full portfolio

Position in NBIX

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$5,682,735

+$1,824,676 QoQ

Shares Held

43,136

+58.6% QoQ

Ownership

0.043%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

25 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

NORDEA INVESTMENT MANAGEMENT AB holds $757,413,866 across 8 Drug Manufacturers - Specialty & Generic names. NBIX ranks #4 (0.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc.	5,865,111	$693,314,769
2	PBH	Prestige Consumer Healthcare Inc.	599,375	$35,524,955
3	UTHR	UNITED THERAPEUTICS Corp	14,255	$8,452,929
4	NBIX	Neurocrine Biosciences Inc This page	43,136	$5,682,735
5	KNSA	Kiniksa Pharmaceuticals International, plc	106,635	$5,134,474
6	TEVA	Teva Pharmaceutical Industries Ltd	124,860	$3,760,783
7	LNTH	Lantheus Holdings, Inc.	41,101	$3,117,510
8	AMPH	Amphastar Pharmaceuticals, Inc.	123,824	$2,425,711

All Filings in NBIX

Export CSV

25 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$5,682,735	43,136	+58.6%	Shares	Defined	2026-05-13
2025-12-31	$3,858,059	27,202	+81.3%	Shares	Defined	2026-01-08
2025-09-30	$2,106,682	15,007	+70.1%	Shares	Defined	2025-10-27
2025-06-30	$1,109,088	8,824	+15.7%	Shares	Defined	2025-07-29
2025-03-31	$843,656	7,628	+0.4%	Shares	Defined	2025-05-14
2024-12-31	$1,037,127	7,598	0.0%	Shares	Sole	2025-01-06
2024-09-30	$875,441	7,598	-72.8%	Shares	Sole	2024-11-05
2024-06-30	$3,846,775	27,942	+4.7%	Shares	Sole	2024-08-08
2024-03-31	$3,680,119	26,683	-0.2%	Shares	Sole	2024-05-02
2023-12-31	$3,524,316	26,748	-6.4%	Shares	Sole	2024-01-10
2023-09-30	$3,216,487	28,591	+205.7%	Shares	Sole	2023-11-13
2023-06-30	$881,987	9,353	-4.3%	Shares	Sole	2023-07-07
2023-03-31	$989,121	9,772	-24.5%	Shares	Sole	2023-04-19
2022-12-31	$1,546,270	12,946	-35.5%	Shares	Sole	2023-02-08
2022-09-30	$2,130,678	20,061	-94.7%	Shares	Sole	2022-10-19
2022-06-30	$36,814,199	377,659	-27.4%	Shares	Sole	2022-08-09
2022-03-31	$48,797,812	520,510	-6.9%	Shares	Sole	2022-04-11
2021-12-31	$47,627,404	559,204	+20.8%	Shares	Sole	2022-01-20
2021-09-30	$44,389,929	462,829	+20.9%	Shares	Sole	2021-11-01
2021-06-30	$37,243,001	382,686	+99.8%	Shares	Sole	2021-07-16
2021-03-31	$18,627,848	191,546	+21.1%	Shares	Sole	2021-05-17
2020-12-31	$15,163,661	158,202	+44.5%	Shares	Sole	2021-02-12
2020-09-30	$10,526,058	109,464	-44.2%	Shares	Sole	2020-11-09
2020-06-30	$23,949,820	196,310	+129.4%	Shares	Sole	2020-08-13
2020-03-31	$7,407,468	85,586	—	Shares	Sole	2020-05-15
No filing history on record for this holder in this stock.